The tissue factor pathway in disseminated intravascular coagulation

Seminars in Thrombosis and Hemostasis

Volumn 27, Issue 6, 2001, Pages 605-617

  Osterud B ^a   Bjorklid E ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

DIC; Disseminated intravascular coagulation; Endothelium; TFPI; Thrombin; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

BLOOD CLOTTING FACTOR 11; CYTOKINE; FIBRIN; PHOSPHATIDYLSERINE; SNAKE VENOM; THROMBIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIUM CELL; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; INJURY; MACROPHAGE; MALIGNANT NEOPLASTIC DISEASE; MENINGOCOCCEMIA; MONOCYTE; NONHUMAN; PERICYTE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SHWARTZMAN PHENOMENON; SOLUTIO PLACENTAE; SURGERY; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; BLOOD COAGULATION; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HUMANS; PREGNANCY; SIGNAL TRANSDUCTION; THROMBOPLASTIN;

EID: 18044385747     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-18866     Document Type: Article

References (111)

1. Disseminated intravascular coagulation: Clinical spectrum and established as well as new diagnostic approaches
2. Disseminated intravascular coagulation
3. Blood-borne tissue factor: Another view of thrombosis
4. Regulation of the procoagulant response to arterial injury
5. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor
6. Cell biology of tissue factor, the principal initiator of blood coagulation
7. Biochemistry and physiology of blood coagulation
8. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade
9. The structural biology of expression and function of tissue factor
10. Activation of factor IX by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation
11. The interaction of human factor VIIa with tissue factor
12. Structural design and molecular evolution of a cytokine receptor superfamily
13. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis
14. The tissue factor pathway: How it has become a "prima ballerina."
15. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation
16. Activation of factor VII bound to tissue factor: A key early step in the tissue factor pathway of blood coagulation
17. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation
18. Cellular interactions in hemostasis
19. Tissue factor as a tumor procoagulant
20. Inhibition of factor IXa and factor Xa by antithrombin III/heparin during factor X activation
21. Comparative platelet binding and kinetic studies with normal and variant factor IXa molecules
22. Initiation and regulation of tissue factor-dependent blood coagulation
23. Tissue factor pathway inhibitor and the revised theory of coagulation
24. Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets
25. Tissue factor pathway inhibitor and the current concept of blood coagulation
26. Factor XIa induced activation of the intrinsic cascade in vivo
27. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody
28. Tissue factor: Identification and characterization of cell types in human placentae
29. Immunohistochemical detection of tissue factor (TF) on paraffin sections of routinely fixed human tissue
30. Tissue factor localization in non-human primate cerebral tissue
31. Astrocytes are the primary source of tissue factor in the murine central nervous system. A role for astrocytes in cerebral hemostasis
32. Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization
33. Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation
34. Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignancies
35. Activation of coagulation and angiogenesis in cancer: Immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer
36. Tissue factor expression in breast cancer tissues: Its correlation with prognosis and plasma concentration
37. In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease
38. Vascular activation in the histopathogenesis of Hodgkin's disease: Potential role of endothelial tissue factor in intravascular thrombosis and necrosis
39. Fibrin and cancer
40. Tissue factor expression and angiogenesis in human prostate carcinoma
41. Tissue factor expression in human colorectal carcinoma: Correlation with hepatic metastasis and impact on prognosis
42. Combined procoagulant activity and proteolytic activity of acute promyelocytic leukemic cells: Reversal of the bleeding disorder by cell differentiation
43. The expression of tissue factor antigen and activity on the surface of leukemic cells
44. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor
45. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia
46. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)
47. Predictors of fetal mortality in pregnant trauma patients
48. Defibrination after brain-tissue destruction: A serious complication of head injury
49. Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: Relationship to multiple organ dysfunction syndrome
50. Generation of tissue factor by patient monocytes: Correlation to thromboembolic complications
51. Blood coagulation in patients with benign and malignant tumours before and after surgery. Special reference to thromboplastin generation in monocytes
52. The high responder phenomenon: Enhancement of LPS induced tissue factor activity in monocytes by platelets and granulocytes
53. Postoperative elevation of human peripheral blood monocyte tissue factor coagulant activity
54. Tissue factor in plasma of patients with disseminated intravascular coagulation
55. Tissue factor released from leukemic cells
56. Role of tissue factor in disseminated intravascular coagulation
57. Determination of plasma tissue factor antigen and its clinical significance
58. The endotoxin-induced coagulant activity of human monocytes
59. Cultured human endothelial cells generate tissue factor in response to endotoxin
60. Production and availability of thromboplastin in endothelial cells: The effects of thrombin, endotoxin and platelets
61. Thromboplastin synthesis in endothelial cells
62. Fast detection of tissue factor and tissue factor pathway inhibitor messenger RNA in endothelial cells and monocytes by sensitive reverse transcription-polymerase chain reaction
63. Tissue factor expression in monocytes: In vitro compared to ex vivo
64. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin
65. Regulation of the tissue factor gene
66. The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin
67. Some thoughts about localization and expression of tissue factor
68. In vitro generation of procoagulant activity by leukemic promyelocytes in response to cytotoxic drugs
69. Human brain pericytes differentially regulate expression of procoagulant enzyme complexes comprising the extrinsic pathway of blood coagulation
70. Mechanism of tissue factor activation on cells
71. Tissue factor de-encryption: Ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms
72. The stimulatory effect of platelets and platelet membranes on the procoagulant activity of leukocytes
73. Enhancement of mononuclear procoagulant activity by platelet 12-hydroxyeicosatetraenoic acid
74. 12-Hydroxyeicosatetraenoic acid upregulates P-selectin-induced tissue factor activity on monocytes
75. The role of arachidonic acid release and lipoxygenase pathway in lipopolysaccharide-induced thromboplastin activity in monocytes
76. Granulocytes enhance LPS-induced tissue factor activity, in monocytes via an interaction with platelets
77. Platelet activating factor enhancement of lipopolysaccharide-induced tissue factor activity in monocytes: Requirement of platelets and granulocytes
78. Induction of tissue factor expression in whole blood: Lack of evidence for the presence of tissue factor expression in granulocytes
79. Tissue factor associated with platelet/microvesicles
80. TNF 41-62 and TNF 78-96 have distinct effects on LPS-induced tissue factor activity and the production of cytokines in human blood cells
81. Tumor necrosis factor-alpha induces activation of coagulation and fibrinolysis in baboons through an exclusive effect on the p55 receptor
82. Comparison of the capacity of rhTNF-alpha and Escherichia coli to induce procoagulant activity by baboon mononuclear cells in vivo and in vitro
83. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees
84. Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli
85. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia
86. Studies on the inflammatory-coagulant axis in the baboon response to E coli: Regulatory roles of proteins C, S, C4bBP and of inhibitors of tissue factor
87. Interleukin-10 inhibits endotoxin-induced tissue factor mRNA production by human monocytes
88. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees
89. Intravascular coagulation in fulminant meningococcemia
90. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: Related to an unfavourable prognosis
91. Leukocytes, adhesive proteins and disseminated intravascular coagulation: Treatment of DIC with plasma/leukapheresis?
92. The expression of surface tissue factor apoprotein by blood monocytes in the course of infections in early infancy
93. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis
94. Mononuclear phagocyte thromboplastin and endotoxin in patients with secondary bacterial peritonitis
95. Experimental gram-negative septicemia: Thromboplastin generation in mononuclear phagocytes from different anatomical sites
96. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody
97. Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reaction
98. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock
99. Bilateral cortical necrosis of kidneys in cortisone treated rabbits following injection of bacterial toxins
100. Procoagulant activity of peritoneal leukocytes: Effects of cortisone and endotoxin
101. Effect of steroids during Escherichia coli endotoxinaemia in rabbits
102. In vitro effects of HWA and methyprednisolone on lipopolysaccharide (LPS)-induced activation products from human blood cells in whole blood
103. Effects of corticosteroids on the circulation in shock: Experimental and clinical results
104. Corticosteroids inhibit complement-induced granulocyte aggregation. A possible mechanism for their efficacy in shock states
105. The generalized Shwartzman reaction: Effects of corticosteroids on thromboplastin synthesis by monocytes
106. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock
107. Lack of ability to synthesize tissue factor by endothelial cells in intact human saphenous veins
108. Thromboplastin content in the vessel walls of different arteries and organs of rabbits
109. Lipopolysaccharide induction of tissue factor expression in rabbits
110. Enhanced endothelial tissue factor but normal thrombomodulin in endotoxin-treated rabbits
111. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis